This site is intended for healthcare professionals in the UK only. Prescribing information and Adverse Event (AE) reporting details can be found in the footer.

Why Zegluxen®
Cost savings
How to Administer
Safety & Tolerability
Supporting information
- FAQs

Why Zegluxen®
Cost savings
How to Administer
Safety & Tolerability
Supporting information
- FAQs

Supporting information and resources

Additional information for healthcare professionals and your patients

Additional information for healthcare professionals and your patients

Please see some important resources for you below:

Zegluxen^® SmPC
Zegluxen ^® patient information leaflet

More resources for both you and your patients to follow.

000799343 | November 2025

Prescribing information can be found here

Navigation

MORE ABOUT US

Reporting of side effects

Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard. Adverse events should also be reported to Zentiva Pharma UK Ltd via our online form (https://www.zentiva.co.uk/contact/mi-form), by email (UKMedInfo@zentiva.com) or by telephone (0800 090 2408).

I confirm I am a UK Healthcare Professional (HCP)

This page is dedicated to UK HCPs only. If you are not a UK HCP, you will be directed to the gateway page after clicking on No.

No, I am not

Yes, I am